Vedere Bio

Gene therapy startup Vedere to close two years after launch
BioPharma Dive
Sun, 04/2/23 - 04:20 pm
Vedere Bio
Novartis
gene therapy
Novartis sharpens focus on vision-restoring gene therapy with $150M Vedere buyout
Fierce Biotech
Thu, 10/29/20 - 11:59 am
Novartis
Vedere Bio
gene therapy
vision loss